Theodore A. Boutacoff
Keine laufenden Positionen mehr
Profil
Theodore A.
Boutacoff was the founder who founded IRIDEX Corp.
in 1989 and served as its Chief Technology Officer from 2011 to 2013.
He also worked as a Director at Biotheranostics, Inc. Additionally, he received his undergraduate degree from Stanford University.
Ehemalige bekannte Positionen von Theodore A. Boutacoff
| Unternehmen | Position | Ende |
|---|---|---|
| IRIDEX CORPORATION | Gründer | 01.02.2013 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Theodore A. Boutacoff
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IRIDEX CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
